Discovering New Medicines in Arizona: Second Annual Drug Discovery and Development Summit

By Liz Mellor, Arizona Center for Drug Discovery and the University of Arizona Cancer Center
Aug. 31, 2020
To: University Communication
From: Arizona Center for Drug Discovery and the University of Arizona Cancer Center
Subject: Discovering New Medicines in Arizona: Second Annual Drug Discovery and Development Summit
Date: Aug 31, 2020

Event Information | Register to Attend

Presented by the Arizona Center for Drug Discovery and the University of Arizona Cancer Center.

The Discovering New Medicines in Arizona Summit will highlight key areas of research in discovering effective drug candidates in prevalent diseases in Arizona while establishing collaborations that enable success in these key areas.

Plenary Speakers

Nicholas A. Meanwell, PhD, vice president, Discovery Chemistry Platforms, Bristol-Myers Squibb Research and Early Development, Princeton, New Jersey
Daniel O. Persky, MD, professor of medicine, College of Medicine - Tucson, associate director of Clinical Investigations, University of Arizona Cancer Center
Jeffrey Trent, PhD, FACMG, president and research director of the Translational Genomics Research Institute (TGen) Phoenix
Grant McFadden, PhD, director and professor, Biodesign Center for Immunotherapy, Vaccines and Virotherapy at Arizona State University

Summit Speakers

  • Roberta Diaz Brinton, PhD, regents professor, director, Center for Innovation in Brain Science, professor, Pharmacology and Neurology, UArizona
  • Bernard Futscher, PhD, professor, Pharmacology and Toxicology, assistant research scientist at the UArizona Cancer Center, co-founder DesertDx 
  • Vijay Gokhale, PhD, associate research professor, BIO5 Institute, UArizona, co-founder Reglagene
  • John-Michael Sauer, PhD, program officer, Biomarker Programs, executive director, Predictive Safety Testing Consortium, C-Path
  • Tara Slkar, JD, MPH, professor of Health Law and Director, Health Law & Policy Program, UArizona
  • George Sutphin, PhD, assistant professor, Molecular and Cellular Biology, assistant professor, BIO5 Institute, UArizona 
  • Gregory Thatcher, PhD, professor, R. Ken and Donna Coit endowed chair in Drug Discovery Department of Pharmacology and Toxicology COP, UArizona 
  • Curtis Thorne, PhD, assistant professor, Cellular and Molecular Medicine, UArizona 
  • Frederic Zenhausern, PhD, MBA, interim co-chair, Department of Basic Medical Sciences, director, Center for Applied NanoBioscience and Medicine, UArizona

Program Timeline

Welcome & Introduction
Rick Schnellmann, PhD, dean & professor, COP, UArizona
8:45 - 9 a.m.

Pre-Session
Moderator: Rick Schnellmann, PhD, dean & professor, COP, UArizona
9 - 9:35 a.m

Plenary Session 
Moderator: Wei Wang, PhD, co-director, Arizona Center for Drug Discovery Professor, Pharmacology and Toxicology, COP, UArizona
9:35 - 11:55 a.m.

Afternoon Session
Moderator: Dan Persky, MD, professor of medicine, COM-T, associate director of clinical investigations, University of Arizona Cancer Center
noon - 2 p.m.

Afternoon Session cont. 
Moderator: Dan Persky, MD, professor of medicine, COM-T, associate director of clinical investigations, University of Arizona Cancer Center
2:15 - 4:15 p.m.

Closing Remarks 
Rick Schnellmann, PhD, dean & professor, COP, UArizona
4:15 - 4:30 p.m.

Resources for the Media